ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z

Abstract Number: 0920

Machine Learning Assisted Prediction of Progression in Systemic Sclerosis Patients: An Approach to Concise, Tailored Model Construction Using Outpatient Clinical Data
Abstract Number: 1732

Machine Learning Coupled with Patient Reported Outcome Data to Classify & Predict RA Disease Activity
Abstract Number: 2017

Machine Learning Identifies an Association Between Pre-existing Radiographic Damage and Long-term Clinical Outcomes with Secukinumab Therapy in Patients with Psoriatic Arthritis
Abstract Number: 0625

Machine Learning Model to Predict Culture Positivity in Suspected Septic Arthritis
Abstract Number: 1365

Machine Learning-based Berlin Scoring of Magnetic Resonance Images of the Spine in Patients with Ankylosing Spondylitis: Analysis of Data from a Phase 3 Trial with Secukinumab
Abstract Number: 1470

Machine Learning-Based Prediction of Knee Replacement in Persons with and Without Radiographic Osteoarthritis Using Clinical and Imaging Features of Osteoarthritis: The Multicenter Osteoarthritis Study
Abstract Number: 0425

MAGIC Syndrome in a Cohort of Patients with Relapsing Polychondritis
Abstract Number: 0447

Magnetic Resonance Imaging Characteristics in Patients with Spondyloarthritis and Clinical Diagnosis of Heel Enthesitis: Screening Data from a Phase 3 Trial
Abstract Number: 1116

Magnetic Resonance Imaging Structural Changes Correlated with Knee Extension: Data from the Osteoarthritis Initiative
Abstract Number: 0939

Maintenance of Remission After Withdrawal of Etanercept or Methotrexate in Patients with Rheumatoid Arthritis in Sustained Remission on Combination Therapy: Results from a Randomized, Double-blind, Controlled Trial
Abstract Number: 0508

Maintenance or Achievement of Minimal Disease Activity Following Therapy Optimization with Adalimumab or Methotrexate in Patients with Psoriatic Arthritis: Results from Part 2 of a Randomized, Open-Label Phase 4 Study
Abstract Number: 1774

Making Decisions About Medication Use, Pregnancy, and Having Children Among Women with Rheumatoid Arthritis: A Constructivist Grounded Theory Study
Abstract Number: 1326

Malignancy Risk Among Patients with Ankylosing Spondylitis in the United States: A Population-Based National Study
Abstract Number: 1628

Management of Gout After Pegloticase; Observations of US Clinical Practice from Trio Health and the American Rheumatology Network (ARN)
Abstract Number: 1629

Management of Gout with Pegloticase; Real-World Utilization and Outcomes from Trio Health and the American Rheumatology Network (ARN)
Abstract Number: 0001

Management of Rheumatic Diseases During COVID-19: A National Veterans Affairs Survey of Rheumatologists
Abstract Number: 0550

Mapping Multimorbidity Using Drug Concept Unique Identifiers (RxCUIs) via the Rx-Risk Comorbidity Index
Abstract Number: 0972

Mapping Oligoclonally Expanded T Cells Within the Peripheral and Synovial Immune Landscape of Untreated ACPA+ Rheumatoid Arthritis Patients at the Single Cell Level
Abstract Number: 0948

Mass Cytometry Reveals Activation Heterogeneity of Circulating Neutrophils in Systemic Lupus Erythematosus
Abstract Number: 0513

Mass Spectrometry Identifies Novel Biomarkers in Giant Cell Arteritis, Useful in Patients on Interleukin-6 Receptor Blockade
Abstract Number: 1256

Mast Cells Contribute to the Development of Sialadenitis Associated with Sjögren’s Syndrome via Inducing Tissue Fibrosis by TGFβ Production
Abstract Number: 1780

Maternal and Fetal Outcomes in Pregnant Women with Psoriatic Arthritis: A Systematic Literature Review
Abstract Number: 1767

Maternal Peripartum Outcomes Are Similar to the General Population in Rheumatoid Arthritis Pregnancies
Abstract Number: 0789

Matrix Gla Protein (MGP) Modified with Malondialdehyde/Acetaldehyde Is Increased in Rheumatoid Arthritis and Cardiovascular Patients
Abstract Number: L06

Mavrilimumab (anti GM-CSF Receptor α Monoclonal Antibody) Reduces Time to Flare and Increases Sustained Remission in a Phase 2 Trial of Patients with Giant Cell Arteritis
Abstract Number: 0941

MDHAQ/RAPID3 (multidimensional Health Assessment Questionnaire/routine Assessment of Patient Index Data) Levels Are Elevated in Rheumatology Patients Who Meet 2011 Fibromyalgia (FM) or MDHAQ/FAST3 (fibromyalgia Assessment Screening Tool) Criteria
Abstract Number: 0140

Meaningful Within-Patient Change in WOMAC Domains in Patients with Moderate-To- Severe Osteoarthritis
Abstract Number: 1560

Measuring Asymmetry in Facial Morphea via 3D Stereophotogrammetry
Abstract Number: 1437

Measuring Disease Activity and Functional Status in Patients with Granulomatosis with Polyangiitis (Wegener’s) (GPA)
Abstract Number: 1886

Measuring Physical Activity in AxSpA:Content Validity and Measurement Properties of the New AxSpA-SQUASH
Abstract Number: 1696

Measuring Quality Improvement from CME Participants: Results from the RAPID® CME Initiative
Abstract Number: 0594

Mechanical and Temperature Stress During Biologic Shipments to Rheumatology Patients
Abstract Number: 1658

Mediation of the Association Between Obesity and Osteoarthritis by Blood Pressure, Arterial Stiffness, and Subclinical Atherosclerosis
Abstract Number: 0373

Medical Cannabis in Ankylosing Spondylitis Following Recreational Legalization: A Prospective Cross-sectional Study
Abstract Number: 0576

Medical Savings of Timely Rheumatoid Arthritis Diagnoses
Abstract Number: 1839

Medication Adherence Barriers and Opportunities to Overcome Them Among Patients with SLE
Abstract Number: 0787

MerTK Synovial Expression Correlates with Disease Activity and Treatment Response in Rheumatoid Arthritis Patients
Abstract Number: 1517

Metabolic Regulation of Type 3 Innate Lymphoid Cells by Intestinal Bacteria-Derived Indoles in Ankylosing Spondylitis
Abstract Number: 1408

Metabolic Reprogramming in Memory CD4+ T Cells Is Associated with Immune Cell Dysfunction During Aging
Abstract Number: 0341

Metabolomics Profiling of Human Serum for Discovering Biomarkers to Diagnose Psoriatic Arthritis and Ankylosing Spondylitis with High Specificity
Abstract Number: 0031

Metabolomics Profiling Predicts Outcome of Tocilizumab in Rheumatoid Arthritis
Abstract Number: 1103

Metacarpo-phalangeal Osteoarthritis Is Not Rare and Is Associated with Mechanical Rather Than Systemic Factors in Hand Osteoarthritis: An Observational Study from a Large Hospital-based Cohort
Abstract Number: 0205

Methotrexate Therapy Is Not Associated with an Increased Risk of Liver Fibrosis Assessed by the Fibrosis-4 Index
Abstract Number: 0181

Methotrexate Use Does Not Increase the Prevalence of Hepatic Steatosis: A Real-World Retrospective Nested Case-Control Study
Abstract Number: 0846

MHC Class I Epitopes Derived from Autoantibody Variable Regions, Conjugated to Synthetic Oligodeoxynuleotides, Induce Cytotoxic T Cells That Deplete Autoreactive B Cells and Ameliorate Murine Lupus
Abstract Number: 0492

Microbiota-induced Intestinal Barrier Dysfunction Initiates the Shuttling of Immune Cells from the Gut to the Joints
Abstract Number: 1675

Microstructural Damage Is Associated with Age at Disease-onset and Cognitive Impairment in Systemic Lupus Erythematosus
Abstract Number: 0077

Mimickers of Immunoglobulin G4-Related Disease
Abstract Number: 1970

Mimicking Cytokine-driven Key Features of Arthritis Using a Human in Vitro 3D Joint Model
Abstract Number: 0795

Minimum Clinically Important Improvement in Patients with Rheumatoid Arthritis Associates with Gut Microbiome
Abstract Number: 0701

miRNome Sequencing Identifies a Unique Profile of Circulating MicroRNAs in Early Knee Osteoarthritis
Abstract Number: 1009

Missing Data and Multiple Imputation in Rheumatoid Arthritis Registries Using Sequential Random Forest Method
Abstract Number: 0957

Mitochondrial ROS as a Regulator of Calcinosis in Juvenile Dermatomyositis
Abstract Number: 1106

MMP Mediated Type I Collagen Degradation Is Associated with Erosive Hand Osteoarthritis in a Hospital-based Observational Cohort – the NOR-HAND Study
Abstract Number: 0613

Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients with Rheumatic Disease
Abstract Number: 0772

Modification of THP-1 Cells with Malondialdehyde-Acetaldehyde Increases Cellular Calcium Load Rendering Cells Susceptible to Citrullination of Self-Proteins
Abstract Number: 0463

Molecular Diagnosis of Childhood Immunodysregulation, Endocrinopathy and Enteropathy X-linked (IPEX)-Like Syndrome and Implications for Clinical Management
Abstract Number: 0036

Molecular Phenotyping of Late-Stage Knee Osteoarthritis Synovium Through Total RNA-Sequencing
Abstract Number: 0453

Monitoring of BK Reactivation and Long-term Safety on JAK1/2 Inhibition with Baricitinib
Abstract Number: 1325

Monoclonal Gammopathy in Psoriatic Arthritis
Abstract Number: 0729

Morbidity of JIA-associated Uveitis: Half of Patients Despite Systemic Treatment Still Show Ocular Damage During a Long-term Follow-up
Abstract Number: 0151

More Than Half of Newly Diagnosed RA Patients Are Not Convinced of the Necessity of RA Medicines: Associations with RA Characteristics, Symptoms, and Function in the Canadian Early Arthritis Cohort (CATCH)
Abstract Number: 0981

Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic Status: The California Lupus Surveillance Project, 2007-2017
Abstract Number: 0854

Mortality and Adverse Events of Special Interest in Adult Patients with Systemic Lupus Erythematosus Receiving Intravenous Belimumab: A Post Hoc Descriptive Summary of Serious Psychiatric Events
Abstract Number: 0582

Mortality and Cost of Hospitalization: Do Hospitals Caring for More SLE Patients Perform Better?
Abstract Number: 0560

Mortality Burden of Immune-Mediated Inflammatory Diseases (IMID): Race/Ethnicity, Sex, and Geographic Variation in the United States
Abstract Number: 1264

Mortality in Patients with Systemic Lupus Erythematosus and Neuropsychiatric Symptoms
Abstract Number: 1606

Mortality with Idiopathic Inflammatory Myositis in an Academic Hospital Setting: A Five-year Retrospective Study
Abstract Number: 0842

mTOR Signaling Pathway Blockade and Rab4 Expression Affects Metabolism of Lupus T Cells
Abstract Number: 0173

mTORC1 Signaling Promotes Monocytosis and Arthritis Development in IL-1 Receptor Antagonist-deficient Mice
Abstract Number: 1194

MUC5B Promoter Variant rs35705950 and Risk Stratification for Rheumatoid Arthritis – Interstitial Lung Disease
Abstract Number: 1195

MUC5B rs35705950 and Rheumatoid Arthritis Associated Interstitial Lung Disease Progression
Abstract Number: 1464

Multi-Variate Approach Including Serology and Genetics for an Improved Identification of Patients at Risk of Developing Rheumatoid Arthritis
Abstract Number: 0342

Multimorbidity Clusters in Psoriatic Arthritis: A Population-Based Study
Abstract Number: 1466

Multimorbidity in Rheumatoid Arthritis, Psoriatic Arthritis, Gout, and Osteoarthritis Within the Rheumatology Informatics System for Effectiveness (RISE) Registry
Abstract Number: 0603

Multisite Study of the Impact of COVID-19 Era Telemedicine Expansion on Reduction in No-Show Rates
Abstract Number: 1266

Multivariate Risk Model Shows Different Risk Factors for Myocardial Infarction and Stroke in SLE
Abstract Number: 1415

Murine Roseolovirus Induces Autoimmune Disease and Development of Autoreactive T Cells and Autoantibodies
Abstract Number: 0687

Musculoskeletal Manifestations in Patients with CD73 Deficiency
Abstract Number: 1711

Musculoskeletal Sarcoidosis Learning Module for Internal Medicine Trainees: Developing a Rheumatology Curriculum
Abstract Number: 0330

Musculoskeletal Surgery in Psoriatic Arthritis: Prevalence and Risk Factors
Abstract Number: PP04

My Multidisciplinary Healthcare Team and Patient Advocacy Groups Saved My Life
Abstract Number: 1823

Mycophenolate Mofetil for Systemic Lupus Erythematosus: Our 20-year Experience
Abstract Number: 1055

Myositis and Systemic Sclerosis Spectrum IPAF Patients Are More Likely to Respond Favorably to Immunosuppression

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z